Europe PTCA Balloon Catheters Market 2020-2028

MARKET OUTLOOK

The publisher's report has determined Europe’s PTCA balloon catheters market would proliferate at a compound annual growth rate of 4.44% during the forecast period 2020-2028. The UK, France, Spain, Germany, Italy, Russia, and Rest of Europe together from the European market for PTCA balloon catheters.
Germany is the key market in Europe for PTCA balloon catheters. This is because the country contributes substantially to the export of catheters to other regions across the world. In addition, the increased investments for research & development in healthcare, growing demand for new, non-invasive devices like catheters, and increased purchasing power have played a crucial role in the development of the PTCA balloon catheters market in Germany. Further, the efforts to promote early disease detection, diagnosis, and treatment in the country have made PTCA balloon catheters a highly lucrative market.

The supportive healthcare infrastructure offers dual health systems, which include private health insurance and statutory health insurance. The insurance and reimbursement facilities provided by the German government are contributing to the ever-increasing demand for balloon catheters in the country. Coronary artery disease is the most widely occurring cardiovascular disease in Germany. It develops as a result of atherosclerosis, and further leads to cardiac arrest. Therefore, the cases of heart-related diseases are growing at an alarmingly high rate, thereby raising the demand for PTCA balloon catheters in the country.

COMPETITIVE OUTLOOK

Major players engaged in the PTCA balloon catheters market are Abbott, Teleflex Incorporated, Biotronik Inc, B Braun Melsungen AG, Boston Scientific Corporation, Koninklijke Philips NV, Medtronic, and Cordis (acquired by Cardinal Health).